Stocks
Allogene Therapeutics (ALLO) Cash US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Cash, bln rub | 457.3 | 517.3 | 448.7 | 292.5 | 250.2 | 266.9 | |||
| Changes by years, y/y, % | -56% | +13% | -13% | -35% | -14% | -24.7% | |||
Allogene Therapeutics. Cash, bln rub
Allogene Therapeutics. Cash, changes, %
Allogene Therapeutics (ALLO) Cash US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Cash, bln rub | 280.0 | 273.1 | 252.2 | 250.2 | 266.9 | 266.9 | ||
| Changes by years, y/y, % | -27% | -39% | -14% | -14% | -5% | |||
| Changes by quarters, q/q, % | -4% | -2% | -8% | -1% | +7% | |||
